Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies

Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View

(2013) Shi Hu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pari passu dimers of dimers

(2012) M. X. Sliwkowski   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TNF-α Blocker Therapy and Solid Malignancy Risk in ANCA-Associated Vasculitis

(2012) Francisco Silva et al.   Current Rheumatology Reports

Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor

(2010) Diego Alvarado et al.   CELL

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

(2010) Alison T. Stopeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Structure of the Complex between HER2 and an Antibody Paratope Formed by Side Chains from Tryptophan and Serine

(2010) Robert D. Fisher et al.   JOURNAL OF MOLECULAR BIOLOGY

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

(2009) Teemu T. Junttila et al.   CANCER CELL

ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor

(2009) Diego Alvarado et al.   NATURE

Development of Novel Tetravalent Anti-CD20 Antibodies with Potent Antitumor Activity

(2008) B. Li et al.   CANCER RESEARCH